We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
+1.8%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$1.34B
AUM Growth
+$275M
Cap. Flow
+$369M
Cap. Flow %
27.6%
Top 10 Hldgs %
52.53%
Holding
297
New
72
Increased
44
Reduced
36
Closed
70

Top Buys

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$54.9M
2
AAPL icon
Apple
AAPL
+$50.6M
3
AMZN icon
Amazon
AMZN
+$48M
4
BAC icon
Bank of America
BAC
+$42.5M
5
BABA icon
Alibaba
BABA
+$31.5M

Sector Composition

Rank Sector Weight
1 Healthcare 37.7%
2 Financials 16.7%
3 Technology 15.54%
4 Consumer Discretionary 9.2%
5 Communication Services 5.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICUI icon
101
ICU Medical
ICUI
$4.21B
$2.73M 0.2%
+11,521
New +$2.69M
FHN icon
102
First Horizon
FHN
$12.2B
$2.69M 0.2%
+165,000
New +$2.75M
NARI
103
DELISTED
Inari Medical, Inc. Common Stock
NARI
$2.68M 0.2%
29,375
-3,823
-12% -$328K
MKL icon
104
Markel Group
MKL
$23.3B
$2.48M 0.19%
2,010
-724
-26% -$914K
REYN icon
105
Reynolds Consumer Products
REYN
$5.26B
$2.44M 0.18%
+77,825
New +$2.27M
SIBN icon
106
CALL
SI-BONE Inc
SIBN
$788M
$2.39M 0.18%
107,500
+38,700
+56% +$833K
SWAV
107
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$2.36M 0.18%
+13,249
New +$2.61M
MRSH
108
Marsh
MRSH
$90.5B
$2.3M 0.17%
+13,223
New +$2.2M
INGN icon
109
Inogen
INGN
$175M
$2.27M 0.17%
66,725
+30,668
+85% +$1.11M
DXCM icon
110
DexCom
DXCM
$32.2B
$2.24M 0.17%
16,704
-2,600
-13% -$374K
CGAU
111
Centerra Gold
CGAU
$3.36B
$2.18M 0.16%
+283,400
New +$2.16M
AMD icon
112
Advanced Micro Devices
AMD
$776B
$2.16M 0.16%
15,000
-45,292
-75% -$6.09M
EW icon
113
Edwards Lifesciences
EW
$49.6B
$2.16M 0.16%
16,656
-8,427
-34% -$983K
MET icon
114
MetLife
MET
$61.9B
$2.16M 0.16%
34,498
-91,616
-73% -$5.75M
IRTC icon
115
iRhythm Holdings
IRTC
$3.85B
$2.12M 0.16%
18,050
-9,630
-35% -$883K
TER icon
116
Teradyne
TER
$57.6B
$2.05M 0.15%
12,515
-22,828
-65% -$3.21M
RS icon
117
Reliance Steel & Aluminium
RS
$20.7B
$1.96M 0.15%
12,100
-9,101
-43% -$1.41M
BHP icon
118
BHP
BHP
$215B
$1.93M 0.14%
+35,872
New +$1.79M
ANGO icon
119
AngioDynamics
ANGO
$611M
$1.79M 0.13%
64,997
+48,869
+303% +$1.35M
HRTX icon
120
Heron Therapeutics
HRTX
$93.9M
$1.7M 0.13%
185,766
+82,921
+81% +$847K
EQH icon
121
Equitable Holdings
EQH
$13B
$1.58M 0.12%
48,274
-1,224
-2% -$40.2K
SPAQ
122
DELISTED
Spartan Acquisition Corp. III
SPAQ
$1.58M 0.12%
160,000
ALL icon
123
Allstate
ALL
$68B
$1.53M 0.11%
+13,001
New +$1.54M
COHR icon
124
Coherent
COHR
$51.4B
$1.5M 0.11%
+22,000
New +$1.38M
APO icon
125
Apollo Global Management
APO
$72.4B
$1.45M 0.11%
+20,000
New +$1.44M

Similar funds

Crestline Management's Q4 2021 Portfolio in Review

As of Q4 2021, Crestline Management held 297 positions worth $1.34B, up 26% from $1.06B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Crestline Management deployed $369M of net new capital in Q4 2021, opening 72 new positions and adding to 44 existing holdings. Its largest new stake was Alphabet (Google) Class C: 380,000 shares worth $55M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 52% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Hartford Financial Services, an estimated $14.5M trimmed.

  • Crestline Management's largest Q4 2021 buy was Alphabet (Google) Class C: 380,000 shares worth $55M.
  • Crestline Management added most to Amazon in Q4 2021, an estimated $48M increase.
  • Crestline Management's biggest Q4 2021 reduction was Hartford Financial Services, cutting an estimated $14.5M.
  • Crestline Management fully exited Zurn Elkay Water Solutions in Q4 2021, selling an estimated $8.75M.
  • Crestline Management's ten largest holdings make up 53% of its $1.34B portfolio in Q4 2021.
  • Crestline Management opened 72 new positions and closed 70 in Q4 2021.
  • Crestline Management's portfolio value rose 26% quarter-over-quarter to $1.34B.

Based on Crestline Management's 13F filing for Q4 2021, filed 14 Feb 2022.